Stem cell therapies for reversing vision loss
Current clinical trials that evaluate human pluripotent stem cell (hPSC)-based therapies predominantly target treating macular degeneration of the eyes because the eye is an isolated tissue that is naturally weakly immunogenic. Here, we discuss current bioengineering approaches and biomaterial usage...
Main Authors: | Higuchi, Akon, Kumar, S. Suresh, Benelli, Giovanni, Alarfaj, Abdullah A., Munusamy, Murugan A., Umezawa, Akihiko, Murugan, Kadarkarai |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Press
2017
|
Online Access: | http://psasir.upm.edu.my/id/eprint/63289/1/Stem%20cell%20therapies%20for%20reversing%20vision%20loss.pdf |
Similar Items
-
Stem cells therapy for treatment of ocular disorders
by: Sivan, Padma Priya, et al.
Published: (2016) -
Biomaterials used in stem cell therapy for spinal cord injury
by: Higuchi, Akon, et al.
Published: (2019) -
Polymeric design of cell culture materials that guide the differentiation of human pluripotent stem cells
by: Higuchi, Akon, et al.
Published: (2017) -
Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects
by: Higuchi, Akon, et al.
Published: (2017) -
Physical cues of cell culture materials lead the direction of differentiation lineages of pluripotent stem cells
by: Higuchi, Akon, et al.
Published: (2015)